‘Not What We Expected,’ R&D Industry Says Of ‘Onerous’ EU Paediatric Regulation

The research-based drug industry has not minced its words in describing the problems it has faced from the EU Paediatric Regulation over the past 10 years.

Papers
The EU Paediatric Regulation Has Introduced An Unnecessary Degree Of Bureaucracy • Source: Shutterstock

More from Clinical Trials

More from R&D